$JNJ Recent Headlines J&J to call for voluntary return

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2014 at 11:04 AM

$JNJ Recent Headlines

J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Johnson & Johnson sees full-year 2014 adjusted EPS of $5.85 to $5.92 7:50 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 sales up 9.1% to $19.5 billion 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 adjusted EPS $1.66 7:49 a.m. July 15, 2014 - William L. Watts
Johnson & Johnson Q2 EPS $1.51 vs. $1.33 a year earlier 7:47 a.m. July 15, 2014 - William L. Watts
The market in a minute: Earnings over politics 10:56 a.m. July 14, 2014 - The Trading Deck
Tech, bank earnings to test economic recovery 6:01 a.m. July 13, 2014 - Wallace Witkowski
Wal-Mart embracing smaller stores in growth strategy 4:05 a.m. July 8, 2014 - Shelly Banjo
How to buy momentum stocks without getting burned 9:22 a.m. July 7, 2014 - Jonathan Burton
What GM could gain from the recall of 29 million cars 4:54 a.m. July 4, 2014 - Tim Mullaney
Whistleblower to get millions for speaking up 8:00 a.m. June 25, 2014 - Al Lewis

Retirement Strategy: Buy The Dips Portfolio Update With Some Stocks On Sale 9:24 a.m. Today - Seeking Alpha
Dividend Investing Over The Past 7 Years Was Never Easy 12:14 a.m. Today - Seeking Alpha
NuVasive Running On Renewed MIS Vigor 12:04 p.m. July 31, 2014 - Seeking Alpha
Bayer Earnings Grow Marginally Y/Y, New Products Encourage - Analyst Blog 10:41 a.m. July 31, 2014 - Zacks.com
Why Johnson & Johnson (JNJ) Stock Is Lower Today 8:37 a.m. July 31, 2014 - TheStreet.com
The 10-Point: Gerard Baker on the U.S. Economy, Lois Lerner's Language, Oil-Boom Airports and More 7:06 a.m. July 31, 2014 - The Wall Street Journal Interactive Edition
Johnson & Johnson Pulls Hysterectomy Tool From Hospitals 7:17 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Merck, J&J, Baxter Provide Healthy Dividend Stream 6:01 p.m. July 30, 2014 - Investors Business Daily
Carlyle Group Swings to a Profit 5:36 p.m. July 30, 2014 - The Wall Street Journal Interactive Edition
Tax Inversion Puts These 3 Mutual Funds in Focus - Best of Funds 2:38 p.m. July 30, 2014 - Zacks.com
Pharma ETFs in Focus on String of Earnings Beat - ETF News And Commentary 2:00 p.m. July 30, 2014 - Zacks.com
Hospira Beats on Earnings and Sales in Q2, Boosts Guidance - Analyst Blog 11:26 a.m. July 30, 2014 - Zacks.com
Undervalued Biotech Stocks Beat the Index 10:42 a.m. July 30, 2014 - Barrons.com
Limiting Risk: A Little Exposure To High Yield Goes A Long Way 5:54 p.m. July 29, 2014 - GuruFocus.com
Top 3 MedTech Stocks, Poised to Gain on Earnings - Earnings ESP 11:38 a.m. July 29, 2014 - Zacks.com
3 Core Dividend Growth Stocks For Retirement Income 10:59 a.m. July 29, 2014 - Seeking Alpha
What's the Right PE Ratio? 9:06 a.m. July 29, 2014 - GuruFocus.com
3 Dividend Stocks Juicing Returns With Buybacks 4:53 a.m. July 29, 2014 - InvestorPlace.com
22 New Stocks to Watch – Mobileye, Synchrony Financial & More 4:49 a.m. July 29, 2014 - InvestorPlace.com
What's The Right PE Ratio? 4:43 a.m. July 29, 2014 - Seeking Alpha

CircleUp Announces Collaboration with Johnson & Johnson Innovation to Identify Transformative Consumer Companies 7:30 a.m. July 31, 2014 - Marketwire
Dendreon Names W. Thomas Amick President and Chief Executive Officer 4:04 p.m. July 30, 2014 - BusinessWire - BZX
Milestone Scientific Appoints Senior Healthcare Industry Executive Steven F. Robins as Marketing Consultant 7:32 a.m. July 30, 2014 - Marketwire
IBM Elects Two New Members to Its Board of Directors 4:34 p.m. July 29, 2014 - BusinessWire - BZX
Accelerator Corporation Secures $51.1 Million to Support Emerging Biotechnology Research Opportunities in New York City and Seattle 7:00 a.m. July 29, 2014 - BusinessWire - BZX
Global Aortic Stent Grafts Market 2014-2018 6:24 p.m. July 28, 2014 - PR Newswire - PRF
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018 4:00 p.m. July 28, 2014 - PR Newswire - PRF
Decision Lens Secures $6.5 Million in Funding to Continue Record-Breaking Growth 12:21 p.m. July 24, 2014 - Marketwire
Abdominal Obesity Global Clinical Trials Review, H1, 2014 4:42 p.m. July 23, 2014 - PR Newswire - PRF
Global Markets for Catheters 3:21 p.m. July 23, 2014 - PR Newswire - PRF
Partial Seizure Global Clinical Trials Review, H2, 2014 1:53 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 1:24 p.m. July 23, 2014 - PR Newswire - PRF
Generalized Seizures Global Clinical Trials Review, H2, 2014 1:17 p.m. July 23, 2014 - PR Newswire - PRF
Financial Results, Campaign Launch, and New Steps in Facility Planning - Research Reports on Johnson & Johnson, Merck, AstraZeneca, Novartis and Teva 8:00 a.m. July 23, 2014 - PR Newswire - PRF
Johnson & Johnson Announces $5 Billion Share Repurchase Program 5:00 p.m. July 21, 2014 - PR Newswire - PRF
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014 11:10 a.m. July 21, 2014 - PR Newswire - PRF
Technical Pointers on Pharma Equities -- AbbVie, Johnson and Johnson, Merck, Bristol-Myers Squibb, and Eli Lilly 8:40 a.m. July 21, 2014 - PR Newswire - PRF
Biotechnology Sector Trends Higher with Breakthrough Clinical Trials, Collaborations & License Agreements 8:15 a.m. July 16, 2014 - PR Newswire - PRF
Autism Global Clinical Trials Review, H1, 2014 1:00 p.m. July 15, 2014 - PR Newswire - PRF
The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016 10:00 a.m. July 15, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BASIS Bellevue Expands with New K-4 Campus

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Yellow River Basin Firms Focus on Global Expansion

Shandong's Bold Move on the Global Stage Imagine the bustling city of Jinan, Shandong's capital, humming with the energy of ambitious enterprises ready to leap into the global arena. That's exactly what unfolded at the conference aimed at forging international ties under the Belt and Road Initiative (BRI). For those out of the loop, this ain't just another business...

H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Smirnoff Launches Marvel Event with $12.99 Offer

Smirnoff's Bold Move to Ride Marvel's Coattails Here we are, watching a vodka brand hitch its wagon to a Hollywood juggernaut. Smirnoff has announced a fan experience to toast Marvel Studios' "Avengers: Doomsday." Of course, this isn't just about clinking glasses; it's a marketing stunt dressed in superhero tights. The impressive part? They’re selling the razzmatazz for...

Markel Stays the Course: Solid Q3 Results in 2026

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

JumpCloud Tackles Compliance in the AI Era

By Kelly Martin Updated Oct 28, 2026 Category News Views 110

Compliance in a Changing Tech Landscape JumpCloud's stepping up in this brave new world riddled with tech and AI agents. They've got fresh platform features in their arsenal that'll keep organizations audit-ready day in and day out. Now, if you think compliance is just for the accountants to fret over, think again. In the agentic era, these advanced marvels—AI agents...

Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Jamaica's Tourism Rebounds Post-Hurricane Challenges

Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...

Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Fidelis Care Opens $120K Workforce Grants for Aid

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...